Literature DB >> 30839290

Carbonic anhydrase II in complex with carboxylic acid-based inhibitors.

Carrie L Lomelino1, Robert McKenna1.   

Abstract

Carbonic anhydrases (CAs) are molecular targets in various diseases. While many sulfonamide-based drugs are in clinical use, CA inhibitor design is moving towards the incorporation of alternative zinc-binding groups, such as carboxylic acids, to promote CA isoform-specific inhibition. Here, X-ray crystal structures of CA II in complex with nicotinic acid and ferulic acid determined to 1.70 and 1.50 Å resolution, respectively, are reported. Furthermore, the structures of these two compounds are superimposed with previously determined structures to compare the mechanisms of inhibition and the properties of carboxylic acid-based CA inhibitors. This study examines an important class of alternative, non-sulfonamide-based CA inhibitors and provides insight to facilitate the structure-guided design of CA isoform-specific inhibitors.

Entities:  

Keywords:  carbonic anhydrase II; carboxylic acids; structure-guided drug design

Mesh:

Substances:

Year:  2019        PMID: 30839290      PMCID: PMC6404860          DOI: 10.1107/S2053230X18018344

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  22 in total

Review 1.  Carbonic anhydrase inhibitors.

Authors:  Claudiu T Supuran
Journal:  Bioorg Med Chem Lett       Date:  2010-06-15       Impact factor: 2.823

2.  Carbonic anhydrase. Purification and nature of the enzyme.

Authors:  D Keilin; T Mann
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

Review 3.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.

Authors:  Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

4.  XDS.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

5.  The catalytic mechanism of carbonic anhydrase. Hydrogen-isotope effects on the kinetic parameters of the human C isoenzyme.

Authors:  H Steiner; B H Jonsson; S Lindskog
Journal:  Eur J Biochem       Date:  1975-11-01

6.  A short, strong hydrogen bond in the active site of human carbonic anhydrase II.

Authors:  Balendu Sankara Avvaru; Chae Un Kim; Katherine H Sippel; Sol M Gruner; Mavis Agbandje-McKenna; David N Silverman; Robert McKenna
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

Review 9.  Recent developments in targeting carbonic anhydrase IX for cancer therapeutics.

Authors:  Paul C McDonald; Jean-Yves Winum; Claudiu T Supuran; Shoukat Dedhar
Journal:  Oncotarget       Date:  2012-01

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.